SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1 (b) (c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2 (b)
(Amendment No. )*
BioCryst Pharmaceuticals, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.01
--------------------------------------------------------------------------------
(Title of Class of Securities)
09058V-10-3
--------------------------------------------------------------------------------
(CUSIP Number)
October 14, 2005
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 09058V-10-3 13G
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Joseph Edelman
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_]
(b) [X]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
1,651,828
-----------------------------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON 1,095,828
WITH -----------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
556,000
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,651,828
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.33%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 2 of 13 Pages
CUSIP No. 09058V-10-3 13G
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Larry Chachkes
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_]
(b) [X]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
390,000
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
390,000
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
1.5%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 3 of 13 Pages
CUSIP No. 09058V-10-3 13G
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Michael Cho
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_]
(b) [X]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
16,000
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,000
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.06%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 4 of 13 Pages
CUSIP No. 09058V-10-3 13G
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Thomas Turalski
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_]
(b) [X]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
150,000
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
150,000
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.56%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 5 of 13 Pages
Item 1.
(a) Name of Issuer.
BioCryst Pharmaceuticals, Inc.
(b) Address of Issuer's Principal Executive Offices.
2190 Parkway Lake Drive
Birmingham, Alabama 35244
Item 2.
(a) Name of Person Filing.
This Schedule 13G is being filed with respect to shares of Common
Stock of the Issuer which are beneficially owned by Joseph Edelman,
Larry Chachkes, Michael Cho and Thomas Turalski (collectively, the
"Reporting Persons"). See Item 4 below.
(b) Address of Principal Business Office or, if none, Residence.
The principal business address of each of the Reporting Persons is:
c/o First New York Securities, LLC
850 Third Avenue, 8th Floor
New York, NY 10022
(c) Citizenship.
Each Reporting Person is a United States citizen.
(d) Title of Class of Securities.
Common Stock, par value $.01
(e) CUSIP Number.
09058V-10-3
Page 6 of 13 Pages
Item 3. If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c),
check whether the person filing is a:
(a) |_| Broker or dealer registered under Section 15 of the Act.
(b) |_| Bank as defined in Section 3(a)(6) of the Act.
(c) |_| Insurance Company as defined in Section 3(a)(19) of the Act.
(d) |_| Investment Company registered under Section 8 of the Investment
Company Act.
(e) |_| Investment Adviser in accordance with Sec.
240.13d-1(b)(1)(ii)(E).
(f) |_| Employee Benefit Plan or Endowment Fund in accordance with Sec.
240.13d"1(b)(1)(ii)(F).
(g) |_| Parent holding company, in accordance with Sec.
240.13d-1(b)(ii)(G).
(h) |_| A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act.
(i) |_| A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act of 1940.
(j) |_| Group, in accordance with Sec. 240.13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to Sec. 240.13d-1(c),
check this box |X|.
Item 4. Ownership
(a) Amount Beneficially Owned.
Mr. Edelman: 1,651,828 (comprised of (i) 1,489,728
shares held by Perceptive Life Sciences Master Fund Ltd.
("Master Fund"), a Cayman Islands company of which the
investment manager is Perceptive Advisors LLC, a
Delaware limited liability company of which Mr. Edelman
is the managing member and (ii) 162,100 shares held in
an account of First New York Trading, LLC ("FNYT"), of
which Mr. Edelman has voting and dispositive power).
Mr. Cho: 16,000 (comprised of (i) 2,500 shares held by
the Master Fund, of which shares Mr. Cho shares
dispositive power with Mr. Edelman and (ii) 13,500
shares held in an account of FNYT, of which Mr. Cho
shares dispositive power with Mr. Edelman).
Mr. Chachkes: 390,000 (comprised of (i) 342,000 shares
held by the Master Fund, of which shares Mr. Chachkes
shares dispositive power with Mr. Edelman and (ii)
48,000 shares held in an account of FNYT, of which Mr.
Chachkes shares dispositive power with Mr. Edelman).
Mr. Turalski: 150,000 shares held by the Master Fund, of
which shares Mr. Chachkes shares dispositive power with
Mr. Edelman.
(b) Percent of Class. Mr. Edelman: 6.33%
Mr. Cho: 0.06%
Mr. Chachkes: 1.5%
Mr. Turalski: 0.57%
Page 7 of 13 Pages
(c) Number of shares as to which each such person has
(i) sole power to vote or to direct the vote:
Mr. Edelman: 1,651,828
Mr. Cho: 0
Mr. Chachkes: 0
Mr. Turalski: 0
(ii) shared power to vote or to direct the vote:
Mr. Edelman: 0
Mr. Cho: 0
Mr. Chachkes: 0
Mr. Turalski: 0
(iii) sole power to dispose or to direct the disposition of:
Mr. Edelman: 1,095,828
Mr. Cho: 0
Mr. Chachkes: 0
Mr. Turalski: 0
(iv) shared power to dispose or to direct the disposition of:
Mr. Edelman: 556,000
Mr. Cho: 16,000
Mr. Chachkes: 390,000
Mr. Turalski: 150,000
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check
the following |_|
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
As referred to in Item 4, other persons have the right to receive
and the power to direct the receipt of dividends from, and the
proceeds from the sale of, certain of the shares reported herein. In
this regard, Master Fund has the right to receive and the power to
direct the receipt of dividends from, and the proceeds from the sale
of, the shares reported herein that are held through the Master
Fund.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company or Control
Person.
See Exhibit B.
Page 8 of 13 Pages
Item 8. Identification and Classification of Members of the Group.
See Exhibit C.
Item 9. Notice of Dissolution of Group.
Not applicable.
Page 9 of 13 Pages
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: October 21, 2005
/s/ Andrew Sankin, as attorney in fact
--------------------------------------
Joseph Edelman
/s/ Larry Chachkes
--------------------------------------
Larry Chachkes
/s/ Michael Cho
--------------------------------------
Michael Cho
/s/ Thomas Turlaski
--------------------------------------
Thomas Turlaski
Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (see 18 U.S.C. 1001).
Page 10 of 13 Pages
EXHIBIT A
AGREEMENT
JOINT FILING OF SCHEDULE 13G
The undersigned hereby agree jointly to prepare and file with regulatory
authorities a Schedule 13G and any amendments thereto reporting each of the
undersigned's ownership of securities of BioCyst Pharmaceuticals, Inc. and
hereby affirm that such Schedule 13G is being filed on behalf of each of the
undersigned.
Date: October 21, 2005
/s/ Andrew Sankin, as attorney in fact
--------------------------------------
Joseph Edelman
/s/ Larry Chachkes
--------------------------------------
Larry Chachkes
/s/ Michael Cho
--------------------------------------
Michael Cho
/s/ Thomas Turlaski
--------------------------------------
Thomas Turlaski
Page 11 of 13 Pages
EXHIBIT B
As discussed in Item 4(a) certain shares reported herein are held through
Perceptive Life Sciences Master Fund Ltd., a Cayman Islands company, of which
Joseph Edelman is the managing member of the fund's investment manager.
Page 12 of 13 Pages
EXHIBIT C
Joseph Edelman, Larry Chachkes, Michael Cho and Thomas Turlaski may be deemed to
constitute a group for purposes of Section 13(d)(3) of the Securities Act of
1934.
Page 13 of 13 Pages